BIOCORP Wins the Pharmapack Award for Its Smart Sensor, Easylog
12 February 2016 - 4:00AM
Business Wire
Regulatory News:
BIOCORP, (Paris:ALCOR) (FR0012788065 – ALCOR / PEA‐PME
eligible), a French company specializing in the development and
manufacturing of innovative medical and drug delivery devices
announces today that it has won the Best Exhibitor Innovation Award
presented by Pharmapack Europe 2016 rewarding Easylog, Biocorp’s
smart sensor. The ceremony was held on February, 11th
at Paris Expo.
The Awards are organized alongside the Pharmapack Europe
conference and exhibition each year from its inception in 1997
onwards, and reward the best innovations in the pharmaceutical
industry every year.
Biocorp’s smart sensor Easylog has received an award in the
category Best Exhibitor Innovation for “customization and
user-friendliness” acknowledged for being an intuitive real time
monitoring tool for patients and health care professionals.
EasyLog, a smart sensor for drug delivery systems
Easylog is a smart sensor that converts all insulin delivery
devices, reusable as well as disposable, into internet-connected
and communicating devices. Easylog mobile application provides
users with reminders for drug delivery, alerts in case of double
injection, real-time access to patients’ historical data and
personalized logbook.Easylog is an innovative solution that meets
the challenges of personalized medicine and is a crucial tool to
ensure the highest quality of treatment against chronic diseases,
improving the patient’s comfort and providing relevant information
for treatment follow-up to healthcare professionals.
Back in 2015, Biocorp had already been awarded by Pharmapack for
its Datapen, a connected injector pen.
« We are very honored to receive this new Award presented
by Pharmapack Europe. Following Datapen in 2015, it is the turn of
our Easylog smart sensor to be in the public eye. Easylog is a
unique solution that contributes to the increase of the compliance
rates, which are still very low among patients suffering from
chronic diseases. Our contribution in this field aims to improve
the patient’s comfort and data reliability for all stake holders.
We are extremely proud to receive the Pharmapack Award which
highlights once again our innovations and the major progress they
bring”, commented Jacques Gardette, Biocorp’s CEO and founder.
More information:
http://www.biocorpsys.com/treatment-management-solutions
ABOUT PHARMAPACK AWARDS
Coinciding with Pharmapack Europe Exhibition since its first
edition in 1997, the Pharmapack Awards have been rewarding the best
innovations in the pharmaceutical industry every year.
In 2016, Pharmapack Europe awarded two categories within the
framework of the Pharmapack Awards:
- Best Health Products: This award
category is dedicated to the visitors' innovations. The prize will
reward the pharma companies and the suppliers that they have worked
with to develop the product. It can be a health product launch or
an enhancement of an existing product for which the packaging has
been improved.
- The Exhibitor Innovation: This award
will recognize the best innovations among the exhibitors'
innovations displayed in the Innovation Gallery. The jury is made
up of over 380 companies. The award ceremony was held by decisions
makers in the pharmaceutical R&D and purchasing for packaging
fields.
More information:
http://www.pharmapackeurope.com/europe/enter-awards
About BIOCORP
Founded in 2004 in Issoire (near Clermont-Ferrand, France),
Biocorp is a French company specializing in the development and
manufacturing of medical devices and innovative drug delivery
systems. It is listed as ‘Innovative Company’ by the French public
investment bank Bpifrance. With over twenty years of experience and
more than 30 manufactured products, Biocorp is a key player in the
industry, providing drug delivery solutions that meet the evolving
needs of patients. Today, Biocorp continues to innovate in the area
of medical plastics, its core business, and to market traditional
devices (alternative to aluminum capsules, syringe and vial
administration systems) that have been an important source of
recurring income. Its solid expertise and capacity to innovate have
allowed the company to develop new internet-connected products,
including: the DataPen, a reusable smart injection pen that
automatically transmits data to a mobile app, helping patients to
manage their treatment; and treatment management add-ons, which
adapt to existing delivery devices and are compatible with most
injection pens in the market. The company has a team of 43
employees.
Biocorp is listed on Alternext since July 2015 (FR0012788065 –
ALCOR). For more information, please visit: www.biocorp.fr
Follow us on Twitter @BIOCORPSystems
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160211006097/en/
BiocorpJacques GardettePrésident Directeur
Généralinvestisseurs@biocorp.frorEric DessertenneDirecteur Business
Development et CommercialorRelations presseALIZE
RPCaroline Carmagnol & Wendy Rigal, + 33 (0) 1 44 64 36 66
- +33 (0) 6 48 82 18 94biocorp@alizerp.com
Biocorp (EU:ALCOR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biocorp (EU:ALCOR)
Historical Stock Chart
From Apr 2023 to Apr 2024